Michelle Sholzberg

Contributor

Michelle Sholzberg is the head of the division of Hematology-Oncology at St. Michael’s Hospital. Her clinical and research focus is on common anemias, hemostasis and health equity. She has received unrestricted research and educational support from Pfizer.

2 Contributions
by Sophia Wen Michelle Sholzberg

Misleading label creates yet another barrier for IV iron use in pregnancy

In 2021, the FDA and EMA announced a new adverse event label for the use of intravenous (IV) iron in pregnancy. But the label is misleading and could worsen already inequitable access to an important treatment for iron deficiency in pregnancy.
by Michael Fralick John Fralick Michelle Sholzberg

Episode 10 – Interview with Dr. Sholzberg on COVID coagulopathy

1 of 1